BIO-Europe Spring 2019: Evotec CEO Lanthaler On Pharma’s Coming Decade of Productivity
Executive Summary
Werner Lanthaler, CEO of Evotec, spoke to Scrip’s Mike Ward about the fruitfulness and innovation of the current biopharma landscape, predicting that the decade to come will be very good for pharma.